James Hamilton

Company: Arrowhead Pharmaceuticals Inc.

Job title: Chief of Discovery & Translational Medicine

Seminars:

Targeting Complement C3 and Factor B with siRNA: Concept to Clinic 10:00 am

Lessons learned from discovery and early preclinical complement inhibitor studies Using Complement Factor B inhibitors to target the alternative pathway Evaluating safety, tolerability, PK/PD in C3 and Factor B inhibitors to treat renal diseaseRead more

day: Conference Day One

From Bench to Bedside: Streamlining Preclinical Strategies for Effective Complement Drug Development Across Disease Indications 12:30 pm

A comprehensive guide to improving the efficacy measurement and translational success of complement inhibitors. Explore cutting-edge methodologies and best practices in preclinical research to bridge the gap between laboratory findings and clinical application. Conduct detailed dose-response studies to determine the optimal dosing regimen that maximizes efficacy while minimizing toxicity Perform extensive safety and toxicology studies…Read more

day: Pre-Conference Workshop Day